Status:

COMPLETED

A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers

Lead Sponsor:

Pfizer

Conditions:

Healthy

Eligibility:

MALE

21-55 years

Phase:

PHASE1

Brief Summary

This Phase 1 study will evaluate PDE10 enzyme occupancy using Positron Emission Tomography after a single dose of PF-02545920 in Healthy male volunteers.

Eligibility Criteria

Inclusion

  • healthy male volunteers

Exclusion

  • History of orthostatic hypotension
  • History of prior radiation exposure for research purposes, or radiation therapy

Key Trial Info

Start Date :

March 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2014

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT01918202

Start Date

March 1 2014

End Date

September 1 2014

Last Update

November 10 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Karolinska Trial Alliance (KTA) M62

Huddinge, Stockholm County, Sweden, SE- 141 86

A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers | DecenTrialz